← Scroll for more →
Cabaletta Bio, Inc. (CABA)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.92
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.29
P/B Ratio
1.49
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Jennison Associates LLC | 20.03M | $62.0M | 13.25% | +11.06M | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 18.87M | $58.0M | 12.48% | +7.79M | 2026-06-30 |
| Bain Capital Life Sciences Investors, LLC | 17.24M | $53.0M | 11.41% | +7.56M | 2026-06-30 |
| BlackRock, Inc. | 10.75M | $33.0M | 7.11% | +8.38M | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 9.17M | $28.0M | 6.07% | +345.0K | 2026-06-30 |
| State Street Corp | 7.84M | $24.0M | 5.19% | +7.37M | 2026-06-30 |
| Vanguard Capital Management LLC | 7.23M | $22.0M | 4.78% | +3.20M | 2026-06-30 |
| Cormorant Asset Management, LP | 5.00M | $15.0M | 3.31% | -500.0K | 2026-06-30 |
| Price T Rowe Associates Inc | 4.42M | $13.0M | 2.92% | +3.98M | 2026-06-30 |
| Woodline Partners LP | 4.20M | $13.0M | 2.78% | +2.95M | 2026-06-30 |